-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
April 01, 2013 - potential harms related to treatment? … Program
2
Task Force recommendation concluded that the potential
benefits do not outweigh the harms … .9 However, the
balance of benefits and harms of tPSA screening remains
controversial.9,10
In 1999 … ) and long-term
(e.g., mortality, morbidity, function, quality of life,
harms) outcomes. … For all
other comparators (Table A), and all other intermediate
(impact on decisionmaking, harms of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_surveillance.pdf
July 01, 2012 - In women with a palpable for nonpalpable breast abnormality, what are the harms associated with
different … did not identify a
statistically
significant effect of
the following
factors on the
accuracy or harms … the
persons performing
the biopsies to
explore the effect
of such factors on
the accuracy or
harms … Lesions, July 2012 re-assessment
Author, Year Country Type of Biopsy Lesions Accuracy results Harms … In women with a palpable for nonpalpable breast abnormality, what are the harms associated with different
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
January 01, 2020 - Could
this be stated specifically rather than in general
as harms. … Are there other possible harms?
Financial burden on families? … We have clarified this in the methods; ”harms” differ by
KQ. … However, the rest of the report
assesses only maternal harms and does not
consider harms to infants … The eligibility criteria makes clear the
intended population and harms.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01.pdf
May 01, 2005 - The prespecification of
13
particular harms, however, may not be possible for all topics; in … Assessing the Risk of Bias for Harms
Although harms are almost always included as an outcome in intervention … Harms are defined as the “totality of possible adverse
consequences of any intervention, therapy or … the harms and benefits of the treatment. … Better
reporting of harms in randomized trials: an
extension of the CONSORT statement.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-maternal-health-grand-rounds-slides.pptx
January 01, 2023 - 6/13/2023
Key Questions
Key Question 1
What are the effectiveness, comparative effectiveness, and harms … Key Question 2
What are the effectiveness, comparative effectiveness, and harms of pharmacological treatments … Key Question 3
What are the comparative effectiveness and harms of alternative magnesium sulfate (MgSO4 … Are there harms associated with the concomitant use of particular antihypertensive medications during … pressure monitoring
54
Key Question 1: What are the effectiveness, comparative effectiveness and harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-disposition-comments.pdf
October 25, 2022 - We changed "However, treating seizures may
cause adverse effects and harms that may also
contribute … For dietary
risks, we re-examined the diet studies for possible
reporting of harms, and found a total … We have added to the discussion under harms:
"We note that the long-term potential harms of
pharmacological … Many parents are anxious
to know about these long-term harms, particularly
regarding neurocognitive … Regarding the
resolution of eye problems, we had not meant
to imply that ALL harms of vigabatrin are
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_disposition-comments.pdf
May 04, 2015 - Scope of Review, 31 of 274, line 17: The review addresses
reported harms, not harms. … We have added a statement about
the likelihood of underreporting of
harms to the Discussion. … Few studies described
what specific methods they used to collect harms data.” … Appendix G documents these
studies and the reported harms. … Harms are minimal and rare; the most
commonly reported harm is self-limited bleeding.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
December 30, 2015 - enabling us to assess harms across the body of
evidence. … Our systematic review assessed many
harms outcomes. … We assessed harms reported in the
original research. … , enabling us
to assess harms across the body of evidence. … data on harms and withdrawals be better documented.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antenatal-care.pdf
January 01, 2020 - The potential benefits and harms or concerns related
to telemedicine, as opposed to in-person care, … Key Questions and Eligibility Criteria
Key Questions
KQ 1: What are the benefits and harms of different … e.g., portal/phone messages)
• Provider outcomes:
o Provider satisfaction with antenatal care
• Harms … Harms: overdiagnosis, delayed diagnoses, harms to marginalized groups/equity outcomes. … We expect to primarily rely on reported within-study
differences in effects (or harms).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_disposition-comments.pdf
July 08, 2014 - I would worry that if someone
were quoting the child harms summary by itself, it wouldn’t
be as clear … Modified sentence to focus on other harms of maternal depression. … Modified sentence to focus on other harms of maternal depression. … These studies
contributed to the evidence on potential harms with treatment during
pregnancy.” … The
signals noted here are serious harms found in the indirect evidence.
-
effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
October 01, 2007 - has
drawn significant attention to the need for efficient ways to monitor
the potential benefits and harms … This focus is equivalent to finding the
balance between benefits and harms for health care services, … to
integrate clinical trials with other study designs are especially
knotty.3 Reporting benefits and harms … Such harms may not appear in RCTs done in
preparation for licensure applications; they may not even
arise … Improving depiction of benefits and harms:
analyses of studies of well-known therapeutics and review
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
March 01, 2009 - Harms§
3. … • No harms results. … §Harms outcomes are defined by key question 2 and may include but are not limited to:
• Thromboembolic … Timing of Outcomes Measurement:
• Follow-up too short to detect important benefits or harms. … Evidence Table for Studies of Harms
Appendix D-2.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mrsa-screening_research.pdf
June 01, 2013 - MRSA).1 The
objective of the CER was to synthesize comparative studies that examined the benefits or harms … comparative effectiveness of MRSA screening on MRSA acquisition,
infection, morbidity, mortality, harms … Practice Center (BCBSA TEC EPC)
was to synthesize comparative studies that examined the benefits or harms … comparative effectiveness of MRSA screening on MRSA acquisition,
infection, morbidity, mortality, harms … • Harms of screening must be
clearly delineated.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-272-genitourinary-syndrome-disposition-comments.pdf
July 31, 2024 - This
was our intention, so we reorganized the effectiveness and harms findings (i.e., KQ2
and 3) to … We did
not identify any trials assessing the
potential benefits and harms of
screening for GSM and … I agree that sample size was not large enough,
nor was duration of study long enough to
determine harms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
December 31, 2013 - extension of an RCT over 24 weeks
in duration and investigates clinical
outcomes, SAEs, and/or harms … • FDA reports on SAEs and/or harms
• Qualitative studies
• Publications with no original data … We will also assess for
serious and rare harms by including and reviewing harms reports from the FDA … We will report benefits and harms for subgroups of interest including age groups, race,
ethnicity, and … Systematic review: comparative effectiveness
and harms of combination therapy
and monotherapy
for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/genitourinary-symptoms-protocol_0.pdf
July 10, 2023 - Randomized trials are short term, with little long-term efficacy,
adherence, or harms data. … Panel, we have drafted the following key
questions:
• Key Question 1: What is the effectiveness and harms … • Key Question 3: What are the harms (and comparative harms) of hormonal, non-
hormonal, and energy-based … Usual care, or different type or level of surveillance
Outcomes
KQ1: Diagnosis of GSM, potential harms … , results will
be organized by treatment comparison, and then by targeted treatment outcome and
harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-vibration-therapy_disposition-comments.pdf
November 15, 2011 - brief
overview of vibration therapy, including the
current understanding of theoretical benefits and
harms … brief overview of vibration therapy,
including the current understanding of
theoretical benefits and harms … brief overview of vibration therapy,
including the current understanding of
theoretical benefits and harms … brief overview of vibration therapy,
including the current understanding of
theoretical benefits and harms … brief overview of vibration therapy,
including the current understanding of
theoretical benefits and harms
-
effectivehealthcare.ahrq.gov/sites/default/files/presentation.ppt
August 01, 2009 - hierarchy of outcomes may reflect higher to lower acuity or target outcomes followed by collateral ones; harms … of included studies
Examples: summary tables for randomized controlled trials, prevalence studies, harms … Example: Presentation of Harms Data
Summary tables can be specialized for different subgroups of the … Example: Presentation of Harms Data
Presentation of harms data can be challenging. … This example table presents the range of proportions of individuals experiencing a given set of harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - trial data.
3
This comparative effectiveness review summarizes the
evidence on the benefits and harms … strength of
evidence and brief conclusions, based on this review,
of the comparative benefits and harms … Summary of the evidence on comparative effectiveness and harms of
DMARDs for childhood JIA
Strength … Summary of the evidence on comparative effectiveness and harms of
DMARDs for childhood JIA (continued … Summary of the evidence on comparative effectiveness and harms of
DMARDs for childhood JIA (continued
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
September 01, 2011 - Summary of Primary Prevention Trials–Harms .......................................................... … After
reviewing a variety of table and graphical formats for presenting data on benefits and harms, … more effectively
represent complex material and what might be concluded regarding the benefits and harms … Summary of primary prevention trials–harms
Number of Events Increased With Medications and Strength … • What type of evidence is necessary to establish the relative benefits and harms of PBT?